Current and emerging pharmacotherapies for treating vascular malformations
Targeted therapies are shifting management from procedure-centered to biology-guided care. Future progress depends on standardized molecular testing, patient-centered outcomes, and optimized treatment duration to achieve durable disease control with acceptable long-term toxicity.
Authors
- Julien Coulie (ORCID: https://orcid.org/0000-0002-4969-2744)
- Miikka Vikkula
- An Van Damme
- Emmanuel Seront
- Laurence M Boon
Institutions
- de Duve Institute (BE)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2026-03-08
- DOI
- https://doi.org/10.1080/17512433.2026.2641807
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00